Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.10.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Revenues:      
Total revenues $ 251,453 $ 141,102 $ 108,973
Operating costs and expenses:      
Cost of material sales 6,337 5,366 5,571
Amortization of intangibles 15,792 12,120 10,643
Research and development 27,863 26,887 21,221
General and administrative 37,734 28,653 27,653
Total operating costs and expenses 87,726 73,026 65,088
Income from operations 163,727 68,076 43,885
Other income (expense):      
Gain (loss) from Viking 50,187 (2,048) (23,132)
Interest income 13,999 2,060 664
Interest expense (48,276) (13,460) (12,842)
Other income (expense), net (6,307) 2,603 (615)
Total other income (expense), net 9,603 (10,845) (35,925)
Income before income tax expense 173,330 57,231 7,960
Income tax expense (30,009) (44,675) (10,327)
Income (loss) from operations 143,321 12,556 (2,367)
Discontinued operations:      
Gain on sale of Oncology Product Line before income taxes 0 0 1,139
Income tax expense on discontinued operations 0 0 (408)
Income from discontinued operations 0 0 731
Net income (loss) $ 143,321 $ 12,556 $ (1,636)
Basic per share amounts:      
Income (loss) from continuing operations (USD per share) [1] $ 6.77 $ 0.60 $ (0.11)
Income from discontinued operations (USD per share) [1] 0 0 0.04
Net income (loss) - Basic (USD per share) [1] 6.77 0.60 (0.08)
Diluted per share amounts:      
Income (loss) from continuing operations (USD per share) [1] 5.96 0.53 (0.11)
Income from discontinued operations (USD per share) [1] 0 0 0.04
Net (loss) income - Diluted (USD per share) [1] $ 5.96 $ 0.53 $ (0.08)
Weighted average common shares outstanding:      
Basic (shares) 21,160 21,032 20,831
Diluted (shares) 24,067 23,481 20,831
Royalties      
Revenues:      
Total revenues $ 128,556 $ 88,685 $ 59,423
Material sales      
Revenues:      
Total revenues 29,123 22,070 22,502
License fees, milestones and other revenues      
Revenues:      
Total revenues $ 93,774 $ 30,347 $ 27,048
[1] The sum of net income per share amounts may not equal the total due to rounding